Welcome

Consolidate your knowledge of weight management in type 2 diabetes (T2D) and explore:

• The epidemiology, burden and long-term complications associated with T2D
• Current treatment options and new drugs for T2D
• Lifestyle and pharmacological strategies for T2D prevention, weight control and loss
• Factors to consider when choosing T2D treatments
• The importance of patient-centred communication and patient involvement in weight management
• Videos featuring Professor Caroline Apovian discussing weight management in T2D

Meet the expert

Meet our leading expert Professor Caroline Apovian, providing you with your digital learning experience via short integrating digestible videos. Professor Apovian is a leading weight management researcher and has held a position at the forefront of the obesity and nutrition fields for over thirty years.

Introduction to Professor Caroline Apovian

Professor Caroline Apovian

Caroline M. Apovian, MD, FACP, FTOS, DABOM is Co-Director of the Center for Weight Management and Wellness (CWMW) in the Division of Endocrinology, Diabetes, and Hypertension at Brigham and Women’s Hospital and is a Professor of Medicine at Harvard Medical School. As well as being one of the world’s leading weight management experts, she is also a healthcare provider, teacher, New York Times bestselling author and one of the founding creators of the American Board of Obesity Medicine. Professor Apovian’s current research interests include weight change and its effects on adipose tissue metabolism and inflammation, obesity and cardiovascular disease, resolution of type 2 diabetes and cardiovascular disease in the bariatric surgery population, disparities in the treatment of obesity in underserved populations, and novel pharmacotherapeutic agents for the treatment of obesity.

Disclosures: Professor Apovian has participated on advisory boards for Abbott Nutrition, Allergan, Inc., Altimmune, Inc., Cowen and Company, LLC, Curavit Clinical Research, EnteroMedics, EPG Communication Holdings Ltd, Gelesis, SRL Pharma, Jazz Pharmaceuticals, Inc., L-Nutra, Inc., NeuroBo Pharmaceuticals, Inc., Novo Nordisk, Inc., Pain Script Corporation, Real Appeal, Riverview School, Rhythm Pharmaceuticals, Roman Health Ventures, Inc., Scientific Intake Ltd. Co., Tivity Health, Inc., Xeno Biosciences and Zafgen Inc. She has received research funding from NIH, PCORI, Novo Nordisk and GI Dynamics, Inc.